[1]张晓辉,吕智.唑来膦酸联合动脉灌注化疗对骨肉瘤的影响[J].实用骨科杂志,2016,22(11):1006-1009.
[2]Alibolandi M,Abnous K,Mohammadi M,et al.Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation[J].J Control Release,2017,264(1):228-236.
[3]Das D,Rameshbabu AP,Ghosh P,et al.Biocompatible nanogel derived from functionalized dextrin for targeted delivery of doxorubicin hydrochloride to MG 63 cancer cells[J].Carbohydr Polym,2017,171(17):27-38.
[4]杨联军,朱立新,包和婧,等.载阿霉素PLGA纳米微球的制备及其对人骨肉瘤MG63细胞的抑制作用[J].实用医学杂志,2014,43(4):528-531.
[5]Metin E,Mutlu P,Gunduz U.Codelivery of Doxorubicin and DαTocopherol polyethylene glycol 1000 succinate by Magnetic Nanoparticles[J].Anticancer Agents Med Chem,2018;18(8):11381147.
[6]Gaspar VM,Moreira AF,Costa EC,et al.Gasgenerating TPGS-PLGA microspheres loaded with nanoparticles(NIMPS) for codelivery of minicircle DNA and antitumoral drugs[J].Colloids Surf B Biointerfaces,2015,134(10):287-294.
[7]朱昆鹏,张春林.长链非编码RNA NR_036444调节多柔比星抵抗骨肉瘤细胞对多柔比星的敏感性[J].中华肿瘤杂志,2017,39(4):250-255.
[8]Younes I,Rinaudo M.Chitin and chitosan preparation from marine sources.Structure,properties and applications[J].Mar Drugs,2015,13(3):1133.
[9]徐一驰,赵楚翘,刘志辉.海藻酸钠/壳聚糖微载体的研究进展[J].中国生物制品学杂志,2018,31(3):332-336.
[10]Hou X,Liu Y.Preparation and drug controlled release of porous octyl-dextran microspheres[J].J Biomater Sci Polym Ed,2015,26(15):1051-1066.
[11]Sun K,Wang J,Zhang J,et al.DextrangPEI nanoparticles as a carrier for codelivery of adriamycin and plasmid into osteosarcoma cells[J].Int J Biol Macromol,2011,49(2):173180.
[12]Chi Y,Yin X,Sun K,et al.Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models[J].J Control Release,2017,261(1):113-125.
[13]Haghiralsadat F,Amoabediny G,Naderinezhad S,et al.EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment[J].Pharm Res,2017,34(12):2891-2900.
[14]Haghiralsadat F,Amoabediny G,Sheikhha MH,et al.A Novel Approach on Drug Delivery:Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines:[J].Cell J,2017,19(Suppl 1):55-65.
[15]Joo JY,Park GY,An SS A.Biocompatible and biodegradable fibrinogen microspheres for tumor-targeted doxorubicin delivery[J].Int J Nanomedicine,2015,10(Spec Iss):101-111.
[16]吉立静,柯靖,贾兰,等.丝素蛋白作为药物载体材料的研究进展[J].生物医学工程学杂志,2015,32(6):1364-1368.
[17]张丹丹,叶海,平其能,等.明胶的改性及其在医药领域的应用[J].药学进展,2017,41(8):600-607.
[18]朱继翔,陈晓明,彭晔,等.可降解明胶支架与PLGA支架的性能比较[J].合成材料老化与应用,2014,42(1):1-3.
[19]Kamba SA,Ismail M,Husseinalali SH,et al.In vitro delivery and controlled release of Doxorubicin for targeting osteosarcoma bone cancer.[J].Molecules,2013,18(9):10580-10598.
[20]Cheng L,Ke Y,Yu S,et al.Codelivery of doxorubicin and recombinant plasmid pHSP70Plk1shRNA by bacterial magnetosomes for osteosarcoma therapy[J].Int J Nanomedicine,2016,11(1):52775286.
[21]张屹,陈建常,史振满.异种骨支架及其衍生材料治疗骨缺损的研究现状与进展[J].中国矫形外科杂志,2014,22(14):1277-1279.
[22]孙梦洁,金巨楼,杨军星,等.脱钙骨基质在骨缺损修复中的应用与改性研究概况[J].现代口腔医学杂志,2018,32(4):229-233.
[23]Castro AG,Polini A,Azami Z,et al.Incorporation of PLLA micro-fillers for mechanical reinforcement of calcium-phosphate cement[J].J Mech Behav Biomed Mate,2017,71(7):286-294.
[24]Zhao L,Burguera EF,Xu HHK,et al.Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds[J].Biomaterials,2010,31(5):840-847.
[25]徐立虎,夏亚一,韵向东.珊瑚用以骨缺损修复的研究进展[J].中国骨质疏松杂志,2013,19(2):183-184.
[26]蔡高锐,刘威,何勇,等.纳米生物材料在骨组织工程中的应用[J].国际骨科学杂志,2017,38(5):303-306.
[27]Brunello G,Sivolella S,Meneghello R,et al.Powder-based 3D printing for bone tissue engineering[J].Biotechnol Adv,2016,34(5):740-753.
[28]阮世强,邓江,鄢陵,等.聚乳酸/聚羟基乙酸共聚物支架复合骨形态发生蛋白2基因增强的脂肪干细胞促进软骨缺损修复[J].中国组织工程研究,2018,22(6):840-845.
[29]曹一汀,杨文裕,李学敏,等.生长因子在关节软骨损伤修复中的应用进展[J].国际生物医学工程杂志,2017,40(4):280-285.
[30]Lsche D,Fürst W,Falk M,et al.Preparation of a cytostatic-containing bone cement[J].Die Pharmazie,1987,42(2):97.
[31]Guan WY,Yi WT,Zhi MY,et al.Experimental research on the use of an antineoplastic drug with a bone implant[J].Int Orthop,1990,14(4):387-391.
[32]张辉,薛忠林,靳安民,等.包裹多柔比星微球骨水泥体内外抗肿瘤活性研究[J].南方医科大学学报,2010,30(2):278-283.
[33]王鹏飞,阮孝慈,杨富帮.纳米羟基磷灰石/胶原复合材料的研究进展[J].杭州化工,2017,47(2):10-13.
[34]杨联军,荣子杰,张赞杰,等.载ADM-PLGA纳米微球的ADM-PLGA-NHAC制备及其对人骨肉瘤MG63细胞的抑制作用[J].中国临床解剖学杂志,2014,32(5):585-589.
[35]荣子杰,杨联军,张赞杰,等.载ADM-PLGA微球的纳米羟基磷灰石/胶原支架修复兔骨缺损的实验研究[J].实用医学杂志,2014,43(22):3559-3562.
[36]Dizaj SM,Barzegarjalali M,Zarrintan MH,et al.Calcium carbonate nanoparticles as cancer drug delivery system[J].Expert Opin Drug Deliv,2015,12(10):1649-1660.
[37]闫思圻,陈淑花,宫蕾,等.石墨烯/氧化石墨烯的功能化及其载药性能研究[J].化工新型材料,2017,45(2):4-6.
[38]Liu H,Ju C,Chen F,et al.Biomimetic and cell-mediated mineralization of hydroxyapatite by carrageenan functionalized graphene oxide.[J].Acs Appl Mater Interfaces,2014,6(5):3132-3140.
[39]Li J,Jiang H,Ouyang X,et al.CaCO-3/Tetraethylenepentamine-graphene Hollow Microspheres as Biocompatible Bone Drug Carriers for Controlled Release[J].Acs Appl Mater Interfaces,2016,8(44):30027-30036.
[40]Ha SW,Jang HL,Nam KT,et al.Nano-hydroxyapatite modulates osteoblast lineage commitment by stimulation of DNA methylation and regulation of gene expression[J].Biomaterials,2015,65(1):32-42.
[41]Yu W,Sun TW,Qi C,et al.Strontium-doped amorphous calcium phosphate porous microspheres synthesized through A Microwave-Hydrothermal method using fructose 1,6Bisphosphate as an organic phosphorus source:application in drug delivery and enhanced bone regeneration[J].Acs Appl Mater Interfaces,2017,9(4):3306-3317.
[42]He W,Mazumder A,Wilder T,et al.Adenosine regulates bone metabolism via A1,A2A,and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma[J].FASEB J,2013,27(9):3446-3454.
[43]Mediero A,Cronstein BN.Adenosine and bone metabolism.[J].Trends Endocrinol Metab,2013,24(6):290-300.
[44]Zhou ZF,Sun TW,Chen F,et al.Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation.[J].Biomaterials,2017,121(1):1-14.
[45]许晨辉,何阿祥,谢栋,等.介孔钙硅酸盐改性硫酸钙骨水泥的体内降解及成骨性能[J].中国矫形外科杂志,2016,24(6):544-551.
[46]Zhao Y,Song W,Dong W,et al.Phase-shifted PFH@PLGA/Fe3O4 Nanocapsules for MRI/US Imaging and Photothermal Therapy with Near-infrared Irradiation[J].Acs Appl Mater Interfaces,2015,7(26):14231-14242.
[47]Kolosnjajtabi J,Corato RD,Lartigue L,et al.Heat-Generating Iron Oxide Nanocubes:Subtle “Destructurators” of the Tumoral Microenvironment[J].Acs Nano,2014,8(5):4268-4283.
[48]Zhang W,Wang F,Yun W,et al.pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells[J].J Control Release,2016,232(1):9-19.
[49]Kim EC,Leesungbok R,Lee SW,et al.Effects of moderate intensity static magnetic fields on human bone marrow-derived mesenchymal stem cells[J].Bioelectromagnetics,2015,36(4):267-276.
[50]De SR,Russo A,Gloria A,et al.Towards the design of 3D fiber-Deposited poly(-caprolactone)/lron-doped hydroxyapatite nanocomposite magnetic scaffolds for bone regeneration[J].J Biomed Nanotechnol,2015,11(7):1236-1246.
[51]Yang F,Lu J,Ke Q,et al.Magnetic mesoporous calcium sillicate/chitosan porous scaffolds for enhanced bone regeneration and photothermal-chemotherapy of osteosarcoma[J].Sci Rep,2018,8(1):7345.
[52]张琪,倪金虎,林贤丰,等.兔胫骨骨膜去细胞生物支架制备方案的优化[J].中华骨科杂志,2016,36(12):785-794.